Sen. Stabenow and House Oversight Committee Chairwoman Maloney Seek GAO Review of Gilead Taxpayer-Funded COVID-19 Treatment
July 29, 2020
July 29, 2020
WASHINGTON, July 29 -- Rep. Carolyn Maloney, D-New York, chairwoman of the House Oversight and Reform Committee, issued the following news release:
U.S. Senator Debbie Stabenow (MI) and Chairwoman of the House Oversight Committee Carolyn B. Maloney (NY-12) asked the Government Accountability Office (GAO) to investigate the discovery and development remdesivir - the first drug authorized to treat COVID-19. Gilead, the company that owns the drug, collected more than $22.4 billion in t . . .
U.S. Senator Debbie Stabenow (MI) and Chairwoman of the House Oversight Committee Carolyn B. Maloney (NY-12) asked the Government Accountability Office (GAO) to investigate the discovery and development remdesivir - the first drug authorized to treat COVID-19. Gilead, the company that owns the drug, collected more than $22.4 billion in t . . .